Acute cholecystitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Continuously enrolled patients in our department who were diagnosed with AC based on Tokyo Guidelines 2018 and received LC treatment (less than 96 hours from onset to surgery).
Exclusion criteria
Exclusion criteria: 1.Any immunosuppressive state; 2.Uncontrolled underlying diseases (diabetes, autoimmune diseases and liver failure); 3.Pregnancy; 4.Patients who were given antibiotics, anticoagulants or anti-inflammatory drugs prior to treatment; 5.Patients with other acute cholangitis and pancreatic disease, such as cholangitis, pancreatitis, choledocholithiasis, and Mirizzi syndrome.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sex;Age;Body Mass Index;History of abdominal surgery;Preoperative American Association of Anesthesiologists score;Body temperature;Heart rate;Right upper quadran tenderness;Right upper quadrant rebound pain;Murphys sign;Duration of pain symptoms;White blood cell count;ALT;AST;ALP;GGT;Total Bilirubin;Indirect bilirubin;Human Albumin;C reactive protein;Procalcitonin;Gallbladder size;Gallbladder wall thickness;Gallbladder stone incarceration;Pericholecystic effusion; | — |
Countries
China
Contacts
Shenzhen People's Hospital